bioRxivCancer BiologyPreprint
Expression patterns of m6A RNA methylation regulators under apoptotic conditions in various human cancer cell lines
A. Akcaoz-Alasar, B. Saglam, I. Erdogan-Vatansever, B. Akgul
Abstract
The emerging evidence suggests that epitranscriptomics changes play a crucial role in the pathogenesis of cancer. However, expression patterns of m6A RNA modifiers under apoptotic conditions are unknown. We measured the transcript abundance of m6A RNA modifiers under cisplatin- and tumor necrosis factor alpha (TNF-)-induced apoptotic conditions. In general, the abundance of m6A modifiers is increased upon cisplatin treatment whereas TNF- treatment has led to a reduction in their expression. Specifically, cisplatin-induced apoptosis, but not TNF- mediated apoptosis, lowered the abundance of METTL14 and FTO transcripts. Additionally, cisplatin treatment plummeted the abundance of IGF2BP2 and IGF2BP3 readers following cisplatin treatment. These results suggest that differential response of cancer cells to apoptotic inducers could be partially due to m6A RNA modifiers.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Epitranscriptomics m6A analyses reveal distinct m6A marks under tumor necrosis α (TNF-α)-induced apoptotic conditions in HeLa cells
A. A. Alasar, O. Tuncel, … B. Akgul·bioRxiv·May 20, 2023
- Genomewide m6A mapping uncovers dynamic changes in the m6A epitranscriptome of cisplatin-treated apoptotic HeLa cells
- RNA Methylation dynamics regulates cancer stemness through modulation of cell migration and cell proliferation in the spheroidal model of TNBC
Sourav Dey, Swati Shree Padhi, … Ruthrotha Selvi Bharathavikru·bioRxiv·Jul 22, 2025
- Fine-tuning m6A and METTL3 levels have profound impact on cellular proliferation and protein synthesis
Samir F. Watson, Johanna Luige, … Ulf Andersson Ørom·bioRxiv·Apr 14, 2026
- Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14
- Unbiased functional genetic screens reveal essential RNA modifications in human cancer and drug resistance
Cornelius Pauli, Michael Kienhöfer, … Michaela Frye·bioRxiv·Jul 13, 2024